antioxidant/hemorrhage

BACKGROUND OF THE INVENTION Field of the Invention The present invention is directed to methods for preconditioning and/or providing neuroprotection to the animal central nervous system against ischemia, neurodegeneration, trauma and metal poisoning, including associated cognitive, behavioral and

FIELD OF THE INVENTION This invention generally relates to compounds, compositions, and methods for preventing and treating diseases such as intracerebral hemorrhage, cancer or conditions associated with damaged cells, activated lymphocytes, or microbial products. The compounds are curcumin

FIELD OF THE INVENTION This invention pertains to the prevention and treatment of mammalian blood vessel injury. More particularly, this invention relates to an ultrasonication method of solubilizing highly lipophilic antioxidants, such as .alpha.-lipoic acid, for delivery to the lipid membranes of

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates generally to the use of .gamma.-glutamyl antioxidants, particularly .gamma.-glutamyl -cysteine, as cytoprotective agents to prevent reperfusion injury (i.e., hemorrhagic transformation) of the blood-brain barrier

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates generally to the use of .gamma.-glutamyl antioxidants, particularly .gamma.-glutamyl-cysteine, as cytoprotective agents to prevent reperfusion injury (i.e., hemorrhagic transformation) of the blood-brain barrier

The present invention relates to pharmacy and industrial bulk solution package of melatonin, an highly concentrated and versatile solution of melatonin in a substantially water-free carrier mixture of ethanol and polyethoxylated derivative, admixed in an optimal ratio to almost double melatonin